TMO PE Ratio & Valuation, Is TMO Overvalued

Historical Valuation

Thermo Fisher Scientific Inc (TMO) is now in the Fair zone, suggesting that its current forward PE ratio of 24.60 is considered Fairly compared with the five-year average of 24.27. The fair price of Thermo Fisher Scientific Inc (TMO) is between 488.27 to 580.21 according to relative valuation method.

Relative Value

Fair Zone

488.27-580.21

Current Price：501.97

Fair

P/E

EV/EBITDA

EV/EBIT

P/S

P/OCF

P/FCF

Trailing

Forward

Unlock 5-Year Valuation Change

Is Thermo Fisher Scientific Inc (TMO) at a historical peak or a rare bargain? Access the full 5-year trend to find out.

Unlock Now

Thermo Fisher Scientific Inc (TMO) has a current Price-to-Book (P/B) ratio of 4.36. Compared to its 3-year average P/B ratio of 4.33, the current P/B ratio is approximately 0.82% higher. Relative to its 5-year average P/B ratio of 4.79, the current P/B ratio is about -8.84% higher. Thermo Fisher Scientific Inc (TMO) has a Forward Free Cash Flow (FCF) yield of approximately 2.75%. Compared to its 3-year average FCF yield of 3.38%, the current FCF yield is approximately -18.71% lower. Relative to its 5-year average FCF yield of 3.35%, the current FCF yield is about -18.08% lower.

Competitors Valuation Multiple

AI Analysis

The average P/S ratio for TMO competitors is 7.06, providing a benchmark for relative valuation. Thermo Fisher Scientific Inc Corp (TMO.N) exhibits a P/S ratio of 4.83, which is -31.58% above the industry average. Given its robust revenue growth of 7.20%, this premium appears unsustainable.

P/E

P/S

EV/EBITDA

EV/EBIT

Earnings Growth

Market Cap

Performance Decomposition

AI Analysis

Market capitalization of TMO increased by 0.00% over the past 1 year(s). The primary factor behind the change was an decrease in Unknown from 0.00 to 0.00.

The secondary factor is the Unknown, contributed 0.00% to the performance.

Overall, the performance of TMO in the past 1 year(s) is driven by Unknown.

People Also Watch

Frequently Asked Questions

Is TMO currently overvalued or undervalued?

What is Thermo Fisher Scientific Inc (TMO) fair value?

TMO's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. The fair price of Thermo Fisher Scientific Inc (TMO) is between 488.27 to 580.21 according to relative valuation method.

How does TMO's valuation metrics compare to the industry average?

The average P/S ratio for TMO's competitors is 7.06, providing a benchmark for relative valuation. Thermo Fisher Scientific Inc Corp (TMO) exhibits a P/S ratio of 4.83, which is -31.58% above the industry average. Given its robust revenue growth of 7.20%, this premium appears unsustainable.

What is the current P/B ratio for Thermo Fisher Scientific Inc (TMO) as of Mar 09 2026?

As of Mar 09 2026, Thermo Fisher Scientific Inc (TMO) has a P/B ratio of 4.36. This indicates that the market values TMO at 4.36 times its book value.

What is the current FCF Yield for Thermo Fisher Scientific Inc (TMO) as of Mar 09 2026?

As of Mar 09 2026, Thermo Fisher Scientific Inc (TMO) has a FCF Yield of 2.75%. This means that for every dollar of Thermo Fisher Scientific Inc's market capitalization, the company generates 2.75 cents in free cash flow.

What is the current Forward P/E ratio for Thermo Fisher Scientific Inc (TMO) as of Mar 09 2026?

As of Mar 09 2026, Thermo Fisher Scientific Inc (TMO) has a Forward P/E ratio of 24.60. This means the market is willing to pay $24.60 for every dollar of Thermo Fisher Scientific Inc's expected earnings over the next 12 months.

What is the current Forward P/S ratio for Thermo Fisher Scientific Inc (TMO) as of Mar 09 2026?

As of Mar 09 2026, Thermo Fisher Scientific Inc (TMO) has a Forward P/S ratio of 4.83. This means the market is valuing TMO at $4.83 for every dollar of expected revenue over the next 12 months.

TMO Valuation